Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

A clinical prediction rule for identifying South African colorectal cancer patients who will fail to engage in oncology care

Award Number: K43CA268978
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/02/2021
PERIOD OF PERFORMANCE END DATE: 08/31/2026

Group Awards By:

View Award Description

A clinical prediction rule for identifying South African colorectal cancer patients who will fail to engage in oncology care - PROJECT SUMMARY/ABSTRACT Colorectal cancer (CRC) is an emerging public health problem in South Africa (SA). Preliminary research from KwaZulu-Natal (KZN), SA shows that 23% of newly diagnosed CRC patients in the public healthcare sector will fail to engage in oncology care (FEOC). This complicates oncologists’ and oncologic surgeons’ efforts to effectively manage CRC disease in this setting. There are a variety of resource-intensive interventions for addressing FEOC. However, implementing these in all newly diagnosed CRC patients would be unfeasible, given the high patient volumes and existing resource constraints in the SA public healthcare sector. A clinical prediction rule (CPR) is proposed for identifying newly diagnosed SA CRC patients who are at high risk of FEOC, thereby enabling more efficient targeting of these specific, high risk patients for interventions which seek to address FEOC. The CPR will be developed by: 1) Identifying potential predictors of FEOC in CRC populations through a systematic review of the literature and a survey of 109 patients; 2) Constructing an appropriate electronic data collection tool that will streamline prospective data collection for these potential predictors and the study outcome, FEOC, from a cohort of 398 newly diagnosed CRC patients; and 3) Applying machine learning methods to the data to derive and internally validate the CPR. The CPR will be an important first step in tackling the high FEOC rates amongst newly diagnosed CRC patients in KZN, SA and will ultimately contribute toward improving both CRC disease management and patient outcomes in this setting. The proposed K43 research has the potential to be scaled up to the national level, and this will be the basis of a future R01 grant application. Dr. Moodley (K43 applicant) wants to become an independent gastrointestinal cancer epidemiologist and a global leader in CPRs, particularly CPRs that seek to address breakdowns in linkage to care and reduce the burden of disease attributed to gastrointestinal cancers, such as CRC. This award will provide him with protected time to conduct the proposed research and engage in an intensive career development program while based at one of the top universities in SA, the University of KwaZulu-Natal. He will be mentored by esteemed senior researchers from SA (Prof. Thandinkosi Madiba, University of KwaZulu-Natal) and the US (Prof. Ravi Pokala Kiran, Columbia University) who have a strong track record of mentoring young researchers. A research advisory committee, comprised of other senior researchers, will provide additional research and career guidance to Dr. Moodley. This will be coupled with didactic and “hands on” training in the core competencies required to develop CPRs. It is envisioned that by the end of his K43 training, Dr. Moodley will have developed the proposed CPR and generated new preliminary data. He will use this new data to successfully apply for an R01 grant, thus establishing his independence as gastrointestinal cancer epidemiologist and a global leader in CPRs.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $43,925 )
2025	2025	UNIVERSITY OF KWAZULU-NATAL	UNIVERSITY ROAD	DURBAN				ZAF	Cancer Research Manpower	000	5	7/30/2025	NON-COMPETING CONTINUATION	$43,925
														Subtotal = $43,925

Issue Date FY: 2024 ( Subtotal = $57,099 )
2024	2024	UNIVERSITY OF KWAZULU-NATAL	UNIVERSITY ROAD	DURBAN				ZAF	Cancer Research Manpower	000	4	8/1/2024	NON-COMPETING CONTINUATION	$57,099
														Subtotal = $57,099

Issue Date FY: 2023 ( Subtotal = $60,760 )
2023	2023	UNIVERSITY OF KWAZULU-NATAL	UNIVERSITY ROAD	DURBAN				ZAF	Cancer Research Manpower	000	3	9/1/2023	NON-COMPETING CONTINUATION	$60,760
														Subtotal = $60,760

Issue Date FY: 2022 ( Subtotal = $61,520 )
2022	2022	UNIVERSITY OF KWAZULU-NATAL	UNIVERSITY ROAD	DURBAN				ZAF	Cancer Research Manpower	000	2	8/24/2022	NON-COMPETING CONTINUATION	$61,520
														Subtotal = $61,520

Issue Date FY: 2021 ( Subtotal = $58,959 )
2021	2021	UNIVERSITY OF KWAZULU-NATAL	UNIVERSITY ROAD, CHILTONHILL	DURBAN				ZAF	Cancer Research Manpower	000	1	9/2/2021	NEW	$58,959
														Subtotal = $58,959

Grand Total All Awards = $282,263

Top

All Categories

About

Search

Reports

Data Submission

Award Information

A clinical prediction rule for identifying South African colorectal cancer patients who will fail to engage in oncology care

Award Number: K43CA268978

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/02/2021

PERIOD OF PERFORMANCE END DATE: 08/31/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer